DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Jubilant Pharmova Limited — Press Release

NSE 2 hrs ago·10 Aug 2026, 1:54 pm

Jubilant Pharmova

Jubilant Pharmova Limited has announced a press release dated August 10, 2026, which it has filed with the stock exchanges. The company has not yet disclosed the specific content of the communication, leaving investors to wait for further details.

This announcement is significant as it signals that the company intends to share important information with the market. Investors will be keen to understand the nature of the press release and its potential implications for the company's future performance.

Investors should monitor the company's official filings and news updates for the full details of the press release. The market will react once the specific information is made public, so staying informed is key.